Abstract
WHO has declared COVID-19 as a worldwide, public health emergency. The elderly, pregnant women, and people with associated co-morbidities, including pulmonary disease, heart failure, diabetes, and cancer are the most predisposed population groups to infection. Cell-free DNA is a very commonly applied marker, which is elevated in various pathological conditions. However, it has a much higher sensitivity than standard biochemical markers. cfDNA appears to be an effective marker of COVID-19 complications, and also serves as a marker of certain underlying health conditions and risk factors of severe illness during COVID-19 infection. We aimed to present the possible mechanisms and sources of cfDNA released during moderate and severe infections. Moreover, we attempt to verify how efficiently cfDNA increase could be applied in COVID-19 risk assessment and how it corresponds with epidemiological data.
Subject
Virology,Infectious Diseases
Reference127 articles.
1. Structural and physiological changes of the human body upon SARS-CoV-2 infection;J. Zhejiang Univ. Sci. B,2021
2. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients;Proc. Natl. Acad. Sci. USA,2015
3. Breitbach, S., Tug, S., Helmig, S., Zahn, D., Kubiak, T., Michal, M., Gori, T., Ehlert, T., Beiter, T., and Simon, P. (2014). Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS ONE, 9.
4. Stawski, R., Walczak, K., Kosielski, P., Meissner, P., Budlewski, T., Padula, G., and Nowak, D. (2017). Repeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy men. PLoS ONE, 12.
5. C-reactive protein: A valuable marker of sepsis;Intensive Care Med.,2002
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献